-
Oncologic
- Cardiovascular and Renal
-
Anti-Infective
- Reproductive Health
-
Anesthetic and Life Support
- Arthritis
-
OTC/Non-prescription
- Vaccines and Related Biological Products
-
Gastrointestinal
- Endocrine and Metabolic
-
Antiviral
- Obstetrics and Gynecology Devices
-
Pulmonary-Allergy
- Biologics
-
Pediatric
-
Peripheral and Central Nervous System
-
Psychopharmacologic
- about us
- Our Team
- News
- what we do
- our services
- our success
- Clients
- Therapeutic Areas
- Case Studies
-
- contact us
- FDA Advisory Committee Process
- Pete Taft interviews Douglas Greene, Senior Vice President and Senior Scientific Advisor for Sanofi-Aventis about the changing landscape of FDA Advisory Committee hearings.
